Role of DNA methylation in the development of diffuse-type gastric cancer

Digestion

Volumn 83, Issue 4, 2011, Pages 241-249

  Yamamoto, Eiichiro ^a   Suzuki, Hiromu ^a   Takamaru, Hiroyuki ^a   Yamamoto, Hiroyuki ^a   Toyota, Minoru ^a   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Diffuse type gastric cancer; DNA methylation; Epstein Barr virus; Helicobacter pylori

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RISK; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; EPSTEIN BARR VIRUS INFECTION; GASTRITIS; GENE MUTATION; GENETIC DISORDER; HELICOBACTER INFECTION; HUMAN; NONHUMAN; PANGASTRITIS; PRIORITY JOURNAL; STOMACH CANCER;

CADHERINS; DNA METHYLATION; DNA, NEOPLASM; GENE SILENCING; HUMANS; STOMACH NEOPLASMS;

EID: 79151478956     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320453     Document Type: Article

References (80)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66. (Pubitemid 46148091)
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001: 345: 784-789.
3. Yuasa Y: Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003; 3: 592-600. (Pubitemid 37328831)
4. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ: Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998; 93: 1271-1276. (Pubitemid 29076926)
5. Nishibayashi H, Kanayama S, Kiyohara T, Yamamoto K, Miyazaki Y, Yasunaga Y, Shinomura Y, Takeshita T, Takeuchi T, Morimoto K, Matsuzawa Y: Helicobacter pylori - induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol 2003; 18: 1384-1391. (Pubitemid 38045852)
6. Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Sakata K, Kashiwaba M, Satodate R: The sequential accumulation of genetic alterations characteristic of the colorectal adenoma- carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 1995; 176: 249-258.
7. Tamura G, Sato K, Akiyama S, Tsuchiya T, Endoh Y, Usuba O, Kimura W, Nishizuka S, Motoyama T: Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 2001; 81: 593-598. (Pubitemid 32298805)
8. Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R: Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 1996; 87: 1153-1159. (Pubitemid 26420023)
9. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-405. (Pubitemid 28168738)
10. Lee JH, Abraham SC, Kim HS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Rashid A, Hamilton SR, Wu TT: Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 2002; 161: 611-618. (Pubitemid 36142169)
11. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, Yoo NJ, Lee JY: Frequent somatic mutations of the -catenin gene in intestinal-type gastric cancer. Cancer Res 1999; 59: 4257-4260. (Pubitemid 29418739)
12. Ushijima T, Sasako M: Focus on gastric cancer. Cancer Cell 2004; 5: 121-125. (Pubitemid 38283798)
13. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007; 128: 683-692. (Pubitemid 46273572)
14. Toyota M, Issa JP: Epigenetic changes in solid and hematopoietic tumors. Semin Oncol 2005; 32: 521-530.
15. Ushijima T, Okochi-Takada E: Aberrant methylations in cancer cells: where do they come from? Cancer Sci 2005; 96: 206-211. (Pubitemid 40767056)
16. Suzuki H, Tokino T, Shinomura Y, Imai K, Toyota M: DNA methylation and cancer pathways in gastrointestinal tumors. Pharmacogenomics 2008; 9: 1917-1928.
17. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K: Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999; 83: 309-313. (Pubitemid 29455752)
18. Ohmura K, Tamura G, Endoh Y, Sakata K, Takahashi T, Motoyama T: Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype. Hum Pathol 2000; 31: 1031-1035.
19. Tamura G: Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006; 12: 192-198. (Pubitemid 43336916)
20. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG: CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847-2851. (Pubitemid 32691923)
21. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T: Promoter methylation status of E-cadherin, hMLH1, and p16 genes in non-neoplastic gastric epithelia. Am J Pathol 2002; 161: 399-403. (Pubitemid 36142148)
22. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, Ng EK, Chung SC, Sung JJ: Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 2002; 102: 623-628. (Pubitemid 35334471)
23. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 2003; 163: 1551-1556. (Pubitemid 37175101)
24. Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, Hirata K, Itoh F, Tokino T, Mori M, Imai K, Shinomura Y: Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 2007; 26: 4699-4713. (Pubitemid 47067406)
25. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, Sonoda T, Mori M, Imai K, Tokino T, Shinomura Y: Frequent epigenetic inactivation of Dickkopf family genes in human gastrointestinal tumors. Carcinogenesis 2007; 28: 2459-2466. (Pubitemid 350238947)
26. Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y: Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005; 24: 7946-7952. (Pubitemid 41715201)
27. Maruyama R, Akino K, Toyota M, Suzuki H, Imai T, Ohe-Toyota M, Yamamoto E, Nojima M, Fujikane T, Sasaki Y, Yamashita T, Watanabe Y, Hiratsuka H, Hirata K, Itoh F, Imai K, Shinomura Y, Tokino T: Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer. Carcinogenesis 2008; 29: 1312-1318.
28. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-8686. (Pubitemid 29354851)
29. Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T: Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer 2006; 106: 1467-1479.
30. Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM, Lewis FR, Huntsman DG, Pharoah PD, Jankowski JA, Mac- Leod P, Vogelsang H, Keller G, Park KG, Richards FM, Maher ER, Gayther SA, Oliveira C, Grehan N, Wight D, Seruca R, Roviello F, Ponder BA, Jackson CE: Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36: 873-880. (Pubitemid 30003842)
31. Pedrazzani C, Corso G, Marrelli D, Roviello F: E-cadherin and hereditary diffuse gastric cancer. Surgery 2007; 142: 645-657. (Pubitemid 350018845)
32. Cisco RM, Ford JM, Norton JA: Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer 2008; 113(suppl):1850-1856.
33. Pharoah PD, Guilford P, Caldas C: International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001; 121: 1348-1353. (Pubitemid 33140452)
34. Jeanes A, Gottardi CJ, Yap AS: Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 2008; 27: 6920-6929.
35. Carneiro F, Oliveira C, Suriano G, Seruca R: Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. J Clin Pathol 2008; 61: 25-30. (Pubitemid 351158221)
36. Takai D, Jones PA: Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002; 99: 3740-3745. (Pubitemid 34252176)
37. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S: Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26: 16-17.
38. Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R: Quantification of epigenetic and genetic second hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009; 136: 2137-2148.
39. Muretto P, Ruzzo A, Pizzagalli F, Graziano F, Maltese P, Zingaretti C, Berselli E, Donnarumma N, Magnani M: Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients. Ann Oncol 2008; 19: 516-519. (Pubitemid 351325673)
40. Thompson MP, Kurzrock R: Epstein-Barr virus and cancer. Clin Cancer Res 2004; 10: 803-821. (Pubitemid 38198878)
41. Fukayama M, Hino R, Uozaki H: Epstein- Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci 2008; 99: 1726-1733.
42. Akiba S, Koriyama C, Herrera-Goepfert R, Eizuru Y: Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci 2008; 99: 195-201. (Pubitemid 351228470)
43. Uozaki H, Fukayama M: Epstein-Barr virus and gastric carcinoma - viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol 2008; 1: 198-216.
44. Burke AP, Yen TS, Shekitka KM, Sobin LH: Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990; 3: 377-380.
45. Chong JM, Sakuma K, Sudo M, Ushiku T, Uozaki H, Shibahara J, Nagai H, Funata N, Taniguchi H, Aburatani H, Fukayama M: Global and non-random CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus. Cancer Sci 2003; 94: 76-80. (Pubitemid 36575862)
46. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY: Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002; 160: 787-794. (Pubitemid 34224568)
47. Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M: CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res 2006; 12: 2995-3002. (Pubitemid 43837343)
48. Kang GH, Lee S, Cho NY, Gandamihardja T, Long TI, Weisenberger DJ, Campan M, Laird PW: DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest 2008; 88: 161-170. (Pubitemid 351161274)
49. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe- Toyota M, Imai K, Baylin SB, Issa JP: Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999; 59: 5438-5442. (Pubitemid 29526452)
50. Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K: Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 1994; 71: 73-81. (Pubitemid 24246024)
51. Oda K, Koda K, Takiguchi N, Nunomura M, Seike K, Miyazaki M: Detection of Epstein- Barr virus in gastric carcinoma cells and surrounding lymphocytes. Gastric Cancer 2003; 6: 173-178. (Pubitemid 37221568)
52. Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, Rani BR, Sakuma K, Nagai H, Fukayama M: p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 2007; 120: 60-66. (Pubitemid 44901918)
53. Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, Hirohashi S: E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 1996; 87: 843-848. (Pubitemid 26335812)
54. Chen TW, Hsu HM: Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas. World J Gastroenterol 2006; 12: 2168-2173.
55. Waki T, Tamura G, Sato M, Motoyama T: Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 2003; 22: 4128-4133. (Pubitemid 36819653)
56. Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, Ichinose M, Tatematsu M, Ushijima T: Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010; 70: 1430-1440.
57. So K, Tamura G, Honda T, Homma N, Waki T, Togawa N, Nishizuka S, Motoyama T: Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci 2006; 97: 1155-1158. (Pubitemid 44430640)
58. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL: Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003; 52: 502-506. (Pubitemid 36363400)
59. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T: High levels of aberrant DNA methylation in Helicobacter pylori -infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12: 989-995. (Pubitemid 43259882)
60. Ushijima T, Nakajima T, Maekita T: DNA methylation as a marker for the past and future. J Gastroenterol 2006; 41: 401-407. (Pubitemid 43941905)
61. Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H: CpG island hypermethylation of tumor-suppressor genes in H. pylori - infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter 2008; 13: 35-41.
62. Tahara T, Arisawa T, Shibata T, Wang FY, Nakamura M, Sakata M, Nagasaka M, Takagi T, Kamiya Y, Fujita H, Nakamura M, Hasegawa S, Iwata M, Takahama K, Watanabe M, Hirata I, Nakano H: Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion 2007; 75: 54-61. (Pubitemid 46712755)
63. Nakajima T, Maekita T, Oda I, Gotoda T, Yamamoto S, Umemura S, Ichinose M, Sugimura T, Ushijima T, Saito D: Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 2317-2321. (Pubitemid 44877064)
64. Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, Miyazaki Y, Murayama Y, Bonilla-Palacios JJ, Matsuzawa Y: Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35: 1571-1574.
65. Stolte M, Bätz CH, Bayerdörffer E, Eidt S: Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach. Z Gastroenterol 1995; 33: 198-201.
66. Yasunaga Y, Shinomura Y, Kanayama S, Higashimoto Y, Yabu M, Miyazaki Y, Kondo S, Murayama Y, Nishibayashi H, Kitamura S, Matsuzawa Y: Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut 1996; 39: 787-794. (Pubitemid 27049079)
67. Murayama Y, Miyagawa J, Shinomura Y, Kanayama S, Yasunaga Y, Nishibayashi H, Yamamori K, Higashimoto Y, Matsuzawa Y: Morphological and functional restoration of parietal cells in Helicobacter pylori associated enlarged fold gastritis after eradication. Gut 1999; 45: 653-661. (Pubitemid 29492136)
68. Miyazaki T, Murayama Y, Shinomura Y, Yamamoto T, Watabe K, Tsutsui S, Kiyohara T, Tamura S, Hayashi N: E-cadherin gene promoter hypermethylation in H. pylori -induced enlarged fold gastritis. Helicobacter 2007; 12: 523-531. (Pubitemid 47312383)
69. Yamamoto E, Toyota M, Suzuki H, Kondo Y, Sanomura T, Murayama Y, Ohe-Toyota M, Maruyama R, Nojima M, Ashida M, Fujii K, Sasaki Y, Hayashi N, Mori M, Imai K, Tokino T, Shinomura Y: LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori -related enlarged- fold gastritis. Cancer Epidemiol Biomarkers Prev 2008; 17: 2555-2564.
70. Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP: A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nu cleic Acids Res 2004; 32:e38.
71. Takai D, Yagi Y, Habib N, Sugimura T, Ushijima T: Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. Jpn J Clin Oncol 2000; 30: 306-309.
72. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N, Sriuranpong V, Mutirangura A: Distinctive pattern of LINE- 1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 2004; 23: 8841-8846. (Pubitemid 39593298)
73. Estécio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH, Tajara EH, Issa JP: LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2007; 2:e399.
74. Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS: LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 2008; 122: 2767-2773. (Pubitemid 351631379)
75. Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS, Kang GH: Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin Cancer Res 2009; 15: 812-820.
76. Hibi K, Kodera Y, Ito K, Akiyama S, Nakao A: Methylation pattern of CDH13 gene in digestive tract cancers. Br J Cancer 2004; 91: 1139-1142. (Pubitemid 39336253)
77. Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D: PGP9.5 methylation in diffuse-type gastric cancer. Cancer Res 2006; 66: 3921-3927.
78. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong YL, Rashid A, Chan CK, Wong BC: Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006; 55: 463-468.
79. Leung WK, Man EP, Yu J, Go MY, To KF, Yamaoka Y, Cheng VY, Ng EK, Sung JJ: Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in non-cancerous stomach. Clin Cancer Res 2006; 12: 3216-3221. (Pubitemid 43837372)
80. Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, Pilotto A, Annese V, Andriulli A: Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pyloriinfected patients and effect of eradication. Am J Gastroenterol 2007; 102: 1361-1371. (Pubitemid 46976302)